Free Trial

AstraZeneca (AZN) Insider Trading & Ownership

AstraZeneca logo
£100.15 +46.46 (+0.47%)
(As of 11:04 AM ET)

AstraZeneca (LON:AZN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.04%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
£2.38 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get AZN Insider Trade Alerts

Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AZN Insider Buying and Selling by Quarter

AstraZeneca Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/19/2024Tony MokInsiderBuy1,500£126.80£190,200
11/14/2024Pascal SoriotInsiderBuy20,000£102.03£2,040,600
9/13/2024Michel DemareInsiderBuy2,000GBX 118£2,360
12/12/2023Anna ManzInsiderBuy487£101.90£49,625.30
11/22/2023Michel DemareInsiderBuy1,000£101.70£101,700
(Data available from 1/1/2013 forward)

AZN Insider Trading Activity - Frequently Asked Questions

The list of insiders at AstraZeneca includes Anna Manz, Michel Demare, Pascal Soriot, and Tony Mok. Learn more on insiders at AZN.

0.04% of AstraZeneca stock is owned by insiders. Learn more on AZN's insider holdings.

The following insiders have purchased AZN shares in the last 24 months: Anna Manz (£49,625.30), Michel Demare (£338,080), Pascal Soriot (£2,040,600), and Tony Mok (£190,200).

Insiders have purchased a total of 26,987 AZN shares in the last 24 months for a total of £2,618,505.30 bought.

AstraZeneca Key Executives

  • Mr. Pascal Soriot D.V.M. (Age 65)
    M.B.A., CEO & Executive Director
    Compensation: $4.57M
    1 recent trades
  • Dr. Aradhana Sarin M.D. (Age 50)
    CFO & Executive Director
    Compensation: $2.52M
  • Ms. Pam P. Cheng (Age 54)
    EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board
  • Mr. Andrew P. Barnett
    Head of Investor Relations
  • Mr. Jeffrey Pott
    CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board
  • Gonzalo Vina
    Head of Global Media Relations
  • Dr. Ruud Dobber Ph.D.
    Executive Vice-President of BioPharmaceuticals Business Unit
  • Dr. Susan Mary Galbraith M.D. (Age 58)
    Ph.D., Executive Vice President of Oncology Research & Development
  • Mr. Leon Wang
    Executive VP of International & China President
  • Ms. Iskra Reic
    Executive Vice-President of Vaccines & Immune Therapies


This page (LON:AZN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners